Literature DB >> 9225026

Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region.

D B Smith1, N Cuceanu, F Davidson, L M Jarvis, J L Mokili, S Hamid, C A Ludlam, P Simmonds.   

Abstract

We have investigated the ability of different subgenomic fragments to reproduce the phylogenetic relationships observed between six complete genome sequences of GBV-C/hepatitis G virus (HGV). While similar relationships were observed following analysis of part of the 5' non-coding region (5'NCR), for the coding region they were not accurately reproduced for some large fragments or for the majority of fragments of 300 or 600 nucleotides. Analysis of 5'NCR sequences from a large number of isolates, including newly obtained sequences from Pakistan, Zaïre and Scotland, produced separate groupings of Asian, African and European/North American variants. These groupings are associated with specific polymorphisms in the 5'NCR, many of which were covariant and consistent with a proposed secondary structure for this region. The relatively low level of amino acid sequence variation observed between these geographically and phylogenetically defined groups of variants suggests that they are unlikely to display significant biological differences.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225026     DOI: 10.1099/0022-1317-78-7-1533

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  GB virus C/hepatitis G virus groups and subgroups: classification by a restriction fragment length polymorphism method based on phylogenetic analysis of the 5' untranslated region.

Authors:  J F Quarleri; V L Mathet; M Feld; D Ferrario; M P della Latta; R Verdun; D O Sánchez; J R Oubiña
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  High frequencies of HGV and TTV infections in blood donors in Hangzhou.

Authors:  J Yan; L L Chen; Y H Luo; Y F Mao; M He
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

3.  A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany.

Authors:  Jie Yan; Reinhard H Dennin
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

4.  Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases.

Authors:  Jie Yan; Li-Li Chen; Yong-Liang Lou; Xiao-Zhi Zhong
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

5.  Prevalence of GB virus C/Hepatitis G virus infection among various populations in Surabaya, Indonesia, and identification of novel groups of sequence variants.

Authors:  R Handajani; M I Lusida; P Suryohudoyo; P Adi; P B Setiawan; C A Nidom; R Soemarto; Y Katayama; M Fujii; H Hotta
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Evidence against GB virus C infection in dromedary camels.

Authors:  Jack T Stapleton; Donald B Smith; Peter Simmonds
Journal:  Vet Microbiol       Date:  2011-06-30       Impact factor: 3.293

Review 7.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

8.  Structural constraints on RNA virus evolution.

Authors:  P Simmonds; D B Smith
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Deep sequencing identifies two genotypes and high viral genetic diversity of human pegivirus (GB virus C) in rural Ugandan patients.

Authors:  Ria R Ghai; Samuel D Sibley; Michael Lauck; Jorge M Dinis; Adam L Bailey; Colin A Chapman; Patrick Omeja; Thomas C Friedrich; David H O'Connor; Tony L Goldberg
Journal:  J Gen Virol       Date:  2013-09-28       Impact factor: 3.891

10.  Detection of hepatitis G virus RNA in persons with and without known risk factors for blood-borne viral infections in Sweden and Honduras.

Authors:  C Lara; R Halasz; A Sönnerborg; M Sällberg
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.